Skip to main content
Paul Martin, MD, Oncology, Seattle, WA

PaulJosMartinMD

Oncology • Seattle, WA

Professor, Medicine, University of Washington School of Medicine

Join to view full profile

Dr. Martin is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Martin's full profile

Already have an account?

  • Office

    1560 N 115th St
    Seattle, WA 98133
    Phone+1 206-368-5800
    Fax+1 206-606-1025

Education & Training

  • University of Washington School of Medicine
    University of Washington School of MedicineClass of 2010

Certifications & Licensure

  • WA State Medical License
    WA State Medical License 2013 - 2025
  • MA State Medical License
    MA State Medical License 2012 - 2013
  • American Board of Internal Medicine Hematology
  • American Board of Internal Medicine Medical Oncology

Clinical Trials

Publications & Presentations

PubMed

Grant Support

  • Patient Enrollment, Specimen And Data Management, And BiostatisticsNational Institute Of Allergy And Infectious Diseases2009–2011
  • Prevention And Treatment Of Graft-Versus-Host DiseaseNational Cancer Institute2007–2011
  • Long-Term Follow-Up CoreNational Cancer Institute2007–2011
  • Efficacy Of CD28 Antibody For GVHD PreventionNational Center For Research Resources2009–2010
  • Core--Long-Term Follow-Up And Chronic GVHDNational Heart, Lung, And Blood Institute2006–2010
  • Mycophenylate Mofetil For Treatment Of Chronic GVHDNational Cancer Institute2003–2008
  • Function &Fate Of Alloantigen-Specific CD8 Cell In GVHDNational Heart, Lung, And Blood Institute2002–2005
  • Core--Long Term Follow-Up And Chronic GVHDNational Heart, Lung, And Blood Institute2001–2003
  • Core--Long Term Follow-UpNational Cancer Institute2002
  • Temporally Controlled Depletion Of Alloreactive T CellsNational Cancer Institute1999–2002
  • Core--Biological Production ResourceNational Cancer Institute1998–2002
  • Donor CD8 Effector Function In Marrow TransplantationNational Heart, Lung, And Blood Institute1996–2000
  • Placebo Controlled Study Of Lamivudine And Intron A In Chronic Hepatitis BNational Center For Research Resources1997–1998
  • Maintenance And Regulation Of Globin Gene ExpressionNational Heart, Lung, And Blood Institute1996–1997
  • Globin Gene Regulation By GATA-1 And ChromatinNational Heart, Lung, And Blood Institute1996–1997
  • Core--Biological Production FacilityNational Cancer Institute1993–1997
  • Globin Gene Regulation By RC Transcription Factor GATA-1National Heart, Lung, And Blood Institute1994–1995
  • Prevention Of GVHD By Cytotoxic Agents Targeted Against IL-2 ReceptorNational Institute Of Allergy And Infectious Diseases1992–1994
  • Role Of Lymphoid Cells In Allogeneic Marrow EngraftmentNational Institute Of Allergy And Infectious Diseases1990–1993
  • Neural Control Of Cardiac Conduction And ExcitationNational Heart, Lung, And Blood Institute1985–1993
  • Prevention Of Graft Vs-Host DiseaseNational Cancer Institute1987–1991
  • Treatment Acute Non-Lymphocytic LeukemiaNational Cancer Institute1988–1990

Dr. Paul Martin, Dr. Paul Martin, MD, Dr. P Martin, Dr. Paul Jos Martin